Concepedia

James Kost

JK

23

Publications

3.4K

Citations

20

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Lou Ruvo Brain Institute

Inserm

University of Southern California

Cleveland Clinic

James Kost is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1997–2020

23

Publications

23

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

Michael Egan, James Kost, Pierre N. Tariot et al. · New England Journal of Medicine · 2018 · 650 citations · Full text

Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study

Gary J. Myers, Philip W. Davidson, Christopher Cox et al. · The Lancet · 2003 · 575 citations

, , +13

Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

Michael Egan, James Kost, Tiffini Voss et al. · New England Journal of Medicine · 2019 · 535 citations · Full text

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Tony W. Ho, Michel D. Ferrari, David W. Dodick et al. · The Lancet · 2008 · 524 citations

, , +6

Combining dependent P-values

James Kost, Michael McDermott · Statistics & Probability Letters · 2002 · 170 citations

Rows per page

1–5 of 23